Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ELOX

Eloxx Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · ELOX

All alert types
13.45 USD +0.27 +2.05%
As of Oct 30, 2026 Extended hours 13.90 +3.35%
Bid
13.23 × 2
Ask
13.69 × 1
12.99 Day range 13.77
10.95 52-week range 20.98
YTD
+22.16%
1 year
+22.16%
Open
13.35
Prev close
13.18
Mkt cap
54.29M
Vol
13.99K
Avg vol
34.36K
EPS
3.52
P/E
3.82
Div yield
0.00%
More statistics
Low
12.99
High
13.77
Forward P/E
-0.87
Beta
2.61
Short ratio
0.63
Inst. own
43.97%
Dividend
0.00
Ex-div date
Earnings
Dec 23, 2024
50-d avg
6.06
200-d avg
5.01
1y target
55.00

5D chart

Chart tools
Interval
1m5m15m30m
ELOX five-day price chart12.512.813.113.513.8Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-4.91 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E -2.1×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.1×FY 2023: -0.2×FY 2024: -1.2×FY 2025: -2.1×
FY 2016 5y median -0.2× FY 2025
P/S 0.0×
FY 2016: 0.3×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.6×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -1.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: -0.2×FY 2023: -0.1×FY 2024: -0.2×FY 2025: -1.0×
FY 2016 5y median -0.2× FY 2025
P/FCF 0.0×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.1×FY 2023: -0.2×FY 2024: -0.8×FY 2025: 0.0×
FY 2016 5y median -0.1× FY 2025
EV/EBITDA -1.7×
FY 2016: 0.2×FY 2017: 1.2×FY 2018: 1.0×FY 2019: 0.1×FY 2020: 0.4×FY 2021: 0.4×FY 2022: 0.1×FY 2023: -0.4×FY 2024: -5.5×FY 2025: -1.7×
FY 2016 5y median -0.4× FY 2025
EV/Sales 0.0×
FY 2016: -10.5×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 1.6×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield 0.0%
FY 2016: -14460.7%FY 2017: -12988.3%FY 2018: -3893.6%FY 2019: -4140.0%FY 2020: -2805.3%FY 2021: -2004.4%FY 2022: -1471.7%FY 2023: -557.4%FY 2024: -125.3%FY 2025: 0.0%
FY 2016 5y median -557.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -24.5%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -4952.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -38.8%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -11023.9%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -49.4%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 50.3%
FY 2016: -181.3%FY 2017: -99.3%FY 2018: -110.0%FY 2019: -140.5%FY 2020: -338.0%FY 2021: -298.1%FY 2022: 338.3%FY 2023: 75.5%FY 2024: 12.9%FY 2025: 50.3%
FY 2016 5y median 50.3% FY 2025
ROIC 59.0%
FY 2016: -38.7%FY 2017: -95.5%FY 2018: -109.5%FY 2019: -97.3%FY 2020: -132.2%FY 2021: -118.2%FY 2022: -1260.9%FY 2023: 92.8%FY 2024: 13.9%FY 2025: 59.0%
FY 2016 5y median 13.9% FY 2025
ROA -113.8%
FY 2016: -89.6%FY 2017: -85.6%FY 2018: -93.0%FY 2019: -86.3%FY 2020: -130.6%FY 2021: -147.8%FY 2022: -170.7%FY 2023: -996.1%FY 2024: -105.6%FY 2025: -113.8%
FY 2016 5y median -147.8% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 0.0%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -160.9%
FY 2016: 51.5%FY 2017: -449.0%FY 2018: -130.4%FY 2019: -7.6%FY 2020: 41.8%FY 2021: -43.9%FY 2022: 18.7%FY 2023: 49.8%FY 2024: 85.7%FY 2025: -160.9%
FY 2016 FY 2025
EPS (diluted) 42.2%
FY 2016: 68.0%FY 2017: 43.5%FY 2018: 69.4%FY 2019: 8.1%FY 2020: 35.5%FY 2021: -10.7%FY 2022: 56.4%FY 2023: 60.2%FY 2024: 87.3%FY 2025: 42.2%
FY 2016 FY 2025
Free Cash Flow 100.0%
FY 2016: 50.8%FY 2017: -339.9%FY 2018: -95.4%FY 2019: -24.8%FY 2020: 28.6%FY 2021: -24.6%FY 2022: 9.1%FY 2023: 55.1%FY 2024: 67.1%FY 2025: 100.0%
FY 2016 FY 2025

Financial Health

Current Ratio 0.3×
FY 2016: 2.7×FY 2017: 7.2×FY 2018: 6.4×FY 2019: 4.9×FY 2020: 2.6×FY 2021: 4.4×FY 2022: 0.9×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Quick Ratio 0.3×
FY 2016: 2.7×FY 2017: 7.2×FY 2018: 6.4×FY 2019: 4.9×FY 2020: 2.6×FY 2021: 4.4×FY 2022: 0.9×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Debt / Equity -0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.4×FY 2020: 1.2×FY 2021: 0.6×FY 2022: -1.3×FY 2023: -0.2×FY 2024: -0.3×FY 2025: -0.1×
FY 2016 5y median -0.2× FY 2025
Net Debt / EBITDA 0.8×
FY 2016: 0.2×FY 2017: 1.2×FY 2018: 1.0×FY 2019: 0.1×FY 2020: 0.4×FY 2021: 0.5×FY 2022: 0.2×FY 2023: -0.2×FY 2024: -3.5×FY 2025: 0.8×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -6.1×
FY 2016: 0.0×FY 2017: -30.5×FY 2018: -6710×FY 2019: -31.3×FY 2020: -20.9×FY 2021: -33.6×FY 2022: -17.7×FY 2023: -15.0×FY 2024: -2.2×FY 2025: -6.1×
FY 2016 5y median -15.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31